|
|
||||||||
1 From the Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, Boston, Massachusetts; and 2 Immunology and Uveitis Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
| Abstract |
|---|
|
|
|---|
METHODS. Biopsy specimens from the conjunctiva of 10 untreated patients with active OCP and from 5 normal subjects were studied for the expression of m-CSF, macrophages, and proliferating cell nuclear antigen (PCNA), a cell cycle protein, by immunohistochemistry. Dual staining for CD68 (a cell surface marker for macrophages) and PCNA was also performed to identify proliferating macrophages. In addition, fibroblasts isolated from conjunctiva of normal individuals and from patients with OCP were studied for the expression of m-CSF by immunostaining and real-time PCR. To identify the factors that induce m-CSF in conjunctival fibroblasts, the fibroblasts were incubated with different concentrations of interleukin (IL)-1
and tumor necrosis factor (TNF)-
, and the levels of m-CSF mRNA were determined by real-time PCR and the amount of m-CSF produced was determined by enzyme-linked immunosorbent assay (ELISA).
RESULTS. Normal conjunctiva showed weak expression of m-CSF in the conjunctival epithelial cells and stroma. Conjunctival expression of m-CSF protein was significantly (P < 0.0001) increased in conjunctival biopsy specimens from patients with OCP. m-CSF was detected in the infiltrating macrophages, stromal cells (presumably fibroblasts), and conjunctival epithelial cells. Compared with normal control conjunctival tissue, a 1.2-fold increase in the expression of mRNA for m-CSF was detected by real-time PCR in the conjunctival tissue obtained from patients with OCP. Increased expression of m-CSF correlated significantly (P < 0.0004) with an increased stromal accumulation of macrophages in conjunctival biopsy specimens of patients with OCP. A number of these accumulated macrophages (CD68-positive) were found to be proliferating (PCNA-positive). In addition, fibroblasts isolated and cultured from conjunctiva of patients with OCP showed significantly increased (1.7-fold) expression of m-CSF compared with normal conjunctival fibroblasts. When conjunctival fibroblasts were treated with IL-1
or TNF-
, real-time PCR and ELISA detected an increased level of m-CSF.
CONCLUSIONS. An increased expression of m-CSF was observed in conjunctiva from patients with active OCP. There was a positive correlation between expression of m-CSF and accumulation of macrophages in conjunctival biopsy sections obtained from patients with OCP. Increased expression of m-CSF, mainly by conjunctival fibroblasts and infiltrating inflammatory cells, may play an important role in the regulation of local proliferation of macrophages in OCP. In the conjunctiva of patients with OCP, this process could augment or enhance the local inflammatory response and tissue injury consequent to it.
| Introduction |
|---|
|
|
|---|
Local proliferation of macrophages has been identified in various organ-specific injuries, including those occurring in the kidney.1
2
3
5
Most important, the degree of local proliferation of macrophages has been found to be closely associated with the severity of tissue injuries.6
7
Local increase in proliferation of macrophages has been detected in severe renal injuries, including acute renal allograft rejection and crescentic nephritis, and after subtotal nephrectomy.8
9
10
Local proliferation of macrophages has also been implicated in the pathogenesis of various immune-mediated and autoimmune diseases, such as glomerulonephritis and lupus nephritis. Increased levels of macrophage-colony stimulating factor (m-CSF) in the liver, spleen, and kidney were associated with increased infiltration of macrophages in these organs in lupus-prone mouse strains (NZB/W and MRL lpr/lpr).11
Local proliferation of macrophages aggravates macrophage-mediated renal injury in human glomerulonephritis and lupus nephritis.12
Moss and Hamilton13
have shown an elevated level of CSFs in the synovial fluid of patients with rheumatoid arthritis and suggest that proliferation of a subpopulation of human peripheral blood monocytes in the presence of CSFs may contribute to the inflammatory process in rheumatoid arthritis. In a separate study, systemic administration of m-CSF or granulocyte macrophagecolony-stimulating factor (GM-CSF) in the acute methylated bovine serum albumininduced murine arthritis model resulted in an increased accumulation of locally dividing macrophages and in exacerbation of arthritis.7
Recently, it has been shown that CSF could induce in vitro proliferation of a subpopulation of human peripheral blood monocytes.14
Local macrophage proliferation was concomitantly associated with enhanced expression of TNF-
in carbon tetrachlorideinduced chronic liver injury in rats, and this cytokine-induced inflammatory response has been thought to be associated with the development of subsequent liver fibrosis.15
Similarly, increased numbers of alveolar macrophages, caused by local proliferation, appear to be involved in the chronic inflammation of pulmonary fibrosis. m-CSF and GM-CSF produced by lung fibroblasts are thought to regulate local proliferation of alveolar macrophages during chronic inflammatory-fibrogenic lung disorders.16
Although it is known that local proliferation of macrophages can intensify the inflammatory responses and subsequent tissue injuries in various tissues and organs, similar studies have not been performed in patients with OCP. In this study, local proliferation of macrophages in biopsy specimens from the conjunctiva of patients with OCP was studied. Because m-CSF regulates monocyte/macrophage survival and proliferation, we also studied its possible role in local macrophage proliferation in biopsy specimens of conjunctiva from patients with OCP. In addition, the effects of IL-1
and TNF-
on the induction of m-CSF by conjunctival fibroblasts were studied.
| Materials and Methods |
|---|
|
|
|---|
Isolation of Fibroblasts from Conjunctiva
Conjunctival fibroblasts were isolated from normal conjunctiva and from OCP conjunctiva, as describe elsewhere.17
Briefly, conjunctival biopsy specimens were cut into explants of approximately 2 x 2 mm2; placed in tissue culture dishes, and covered with Dulbeccos modified Eagles medium (DMEM; Mediatech, Inc., Herndon, VA), containing fetal bovine serum (FBS; Mediatech, Inc.), gentamicin, and amphotericin B; and incubated overnight at 37°C in 95% humidified incubator with 5% CO2. Twenty-four hours later, more DMEM was added, and the medium was changed three times weekly thereafter. The isolated fibroblasts were subcultured with 0.1% trypsin and 0.02% EDTA in Ca+-free minimum essential medium (MEM) containing penicillin-streptomycin (Atlanta Biologicals, Norcross, GA), until the cells reached 80% to 90% confluence. Fibroblasts from control and OCP conjunctiva were also grown on slides, fixed with methanol, and used for immunostaining. In addition, RNA isolated from conjunctivae of normal control subjects and from patients with OCP were used in real-time PCR studies.
Immunohistochemistry
Immunohistochemistry was performed on paraffin-embedded and on frozen sections of conjunctiva, as described previously.18
19
Briefly, tissue sections were blocked with either 10% goat serum or 10% rabbit serum for 1 hour and then incubated overnight at 4°C with the following primary antibodies: rabbit anti-human m-CSF (Leinco Technologies, St. Louis, MO), mouse anti-human CD68 (Dako, Glostrup, Denmark), and mouse anti-human PCNA (Dako). After a wash in phosphate-buffered saline (PBS), the sections were treated with a secondary antibody for 15 minutes (biotinylated goat anti-mouse IgG for CD68 and PCNA; biotinylated goat anti-rabbit IgG for m-CSF), washed with PBS, and incubated further with streptavidin-peroxidase. The reaction products were developed with a mixture of 3,3'-diaminobenzine-4 HCl (DAB) and H2O2. Both the secondary antibodies and streptavidin-peroxidase solution were from a kit (Histostain; Nichirei Co., Tokyo, Japan). Normal mouse serum was used as a negative control for mouse anti-human CD68 and mouse anti-human PCNA antibodies, and normal rabbit serum was used as a negative control for rabbit anti-human m-CSF antibody. Conjunctival fibroblasts isolated from normal and OCP-affected conjunctiva were grown on glass slides, fixed with methanol, and immunostained for m-CSF, as described earlier. To quantitate the number of m-CSF and CD68-positive macrophages and PCNA-positive proliferating cells, immunostained cells were counted randomly in at least five different fields (magnification, x20) in each biopsy section with the aid of a light microscope (Nikon Corp., Tokyo, Japan). The number of cells in each field from all controls and all patients with OCP was expressed as the mean ± SEM.
Double Immunostaining
Double immunostaining was performed to colocalize m-CSF/CD68 and CD68/PCNA as described previously.20
21
Briefly, m-CSF or PCNA was initially stained by an alkaline phosphatase method and developed with 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium (BCIP-NBT), which produced dark purple staining.22
Then, the m-CSF or PCNA-stained sections of conjunctiva were counterstained for CD68 by a peroxidase method and visualized with H2O2 and 3-amino-9-ethylcarbazole (AEC), producing an intense red stain.23
Effects of IL-1 and TNF-
on the Expression of m-CSF by Conjunctival Fibroblasts
The conjunctival fibroblasts were subcultured and kept in the serum-free medium for 24 hours and then were treated with various concentrations (1, 10 and 100 ng/mL) of IL-1
or TNF-
(R&D Systems, Minneapolis, MN) for 6 hours. Total RNA was extracted from the IL-1
or TNF-
treated fibroblasts, and the level of m-CSF was determined by real-time PCR.
Real-Time PCR
Total RNA isolated from conjunctival tissues and from fibroblasts of control and OCP conjunctiva was used to detect the relative expression of m-CSF mRNA. The principle of real-time quantitative PCR has been described elsewhere.24
25
The quantification of transcription of real-time PCR takes advantage of the 5' nuclease activity of DNA polymerase (AmpliTaq Gold; PE-Applied Biosystems, Foster City, CA). Total RNA was extracted from conjunctival tissues and conjunctival fibroblasts with an RNA isolation kit (Qiagen, Valencia, CA). The primers and probe used for detecting m-RNA for m-CSF are as follows: forward, TGC AGC GGC TGA TTG ACA; reverse, TTC AAC TGT TCC TGG TCT ACA AAC TC, probe (TaqMan; PE-Applied Biosystems); FAM (reporter dye)-TCA GAT GGA GAC CTC GTG CCA AAT TAC ATT-TAMRA (quencher dye). Each PCR reaction contained equivalent amounts of total RNA. Real-time PCR was performed in duplicate with a kit used according to the manufacturers recommendation (TaqMan One-Step RT-PCR Master Mix Reagents; PE-Applied Biosystems). All the reactions were controlled by standards (nontemplate control and standard positive control). While extracting the total RNA from conjunctival fibroblasts, we routinely used DNase to prevent DNA contamination. When real-time PCR was performed without addition of reverse transcriptase, no PCR product was detected, either for m-CSF or the housekeeping gene. Amplified PCR products were sequenced (at the core facility of Harvard Institute of Medicine, Boston, MA), and showed a complete homology with the corresponding sequence of the human m-CSF gene. The quantity of mRNA was calculated by normalizing the threshold cycle level (CT) of m-CSF to the CT of the housekeeping genes 18S ribosomal RNA or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of the same RNA probe, according to the following formula: the mean 18S or GAPDH CT (each multiplex PCR was performed in duplicate) was subtracted from the mean m-CSF CT level. This result represents the change in CT (
CT). This
CT is specific and can be compared with the
CT of a calibration sample (for example, control conjunctiva or control conjunctival fibroblasts). The subtraction of control
CT from the
CT of OCP samples or fibroblasts is referred to as 
CT. The relative quantification of expression of m-CSF in conjunctival tissues and fibroblasts isolated from the conjunctiva of patients with OCP (in comparison with that in the control) was determined by 2-
CT. For all the probes, the quencher dye was 6-carboxy-tetramethylrhodamine (TAMRA), and the reporter dye was 6-carboxy fluorescein (FAM) for m-CSF and VIC for 18S and GAPDH.
Enzyme-Linked Immunosorbent Assay
The conjunctival fibroblasts were subcultured and kept in the serum-free medium for 24 hours and were treated with various concentrations (1, 10, or 100 ng/mL) of IL-1
or TNF-
(R&D Systems) for 24 hours. The supernatant was collected and the level of m-CSF was determined with an ELISA kit (R&D Systems), according to the manufacturers protocol.
Statistical Analysis
Data were expressed as the mean ± SEM. Differences between groups were examined for statistical significance using the t-test or one-way ANOVA. Correlations were examined by liner regression analysis. P < 0.05 denoted the presence of a statistically significant difference.
| Results |
|---|
|
|
|---|
|
|
Proliferating Cell Nuclear Antigen.
Scattered PCNA-positive cells were detected in the conjunctival epithelial cells in control conjunctival sections (Fig. 1E)
. In contrast, a higher number of PCNA-positive cells was present in conjunctival sections from patients with OCP (Fig. 1F)
. Those cells were found to be macrophages, stromal fibroblasts, and conjunctival epithelial cells. The number of PCNA-positive cells was significantly increased (control, 2.35 ± 0.21; OCP, 22.35 ± 0.83, P < 0.0001) in conjunctival sections obtained from patients with OCP, compared with control conjunctiva (Fig. 2C)
. When the conjunctival sections were incubated with mouse serum instead of monoclonal PCNA antibody, no specific staining was detected.
Proliferating Macrophages.
To identify proliferating macrophages in conjunctival sections, CD68-positive macrophages were counterstained for the cell-cycle protein PCNA. A significant number of accumulated macrophages were PCNA positive, indicating the presence of proliferating macrophages in the sections of conjunctiva obtained from patients with OCP.
Correlation between Increased Expression of m-CSF and Increased Accumulation of Macrophages
To examine the relationship between the expression of m-CSF and accumulated macrophages, we counted the number of m-CSFpositive cells and CD68-positive macrophages in the conjunctival sections obtained from patients with OCP and performed a correlation analysis. As shown in Figure 2D
, a positive correlation between the expression of m-CSF and accumulation macrophages was found in the conjunctiva obtained from patients with OCP (r = 0.4718, P < 0.0004).
Expression of m-CSF in Fibroblasts
Fibroblasts isolated from conjunctiva of normal individuals and patients with OCP were studied by immunostaining and real-time PCR, to clarify the possible role of these fibroblasts in the expression of m-CSF. Compared with the fibroblasts isolated from control conjunctiva (Fig. 3A)
, increased cytoplasmic immunostaining for m-CSF was seen in fibroblasts isolated from conjunctiva of patients with OCP (Fig. 3B)
. A similar expression pattern was also noted by real-time PCR analysis of total RNA extracted from fibroblasts. Compared with the fibroblasts isolated from control conjunctiva, a 1.7-fold increase in the expression of m-CSF mRNA was seen in the fibroblasts isolated from conjunctiva of patients with OCP, by quantitative real-time PCR.
|
and TNF-
on the Expression of m-CSF in Fibroblasts
or TNF-
(Table 1)
, an increased level of m-CSF was detected in the supernatant. Similarly, increased expression of m-CSF was detected by quantitative real-time PCR analysis in both IL-1
and TNF-
-treated conjunctival fibroblasts (Fig. 4)
.
|
|
| Discussion |
|---|
|
|
|---|
m-CSF, also known as CSF-1, regulates the survival, proliferation, and differentiation of mononuclear phagocytes. Numerous studies have shown a close association between the expression of m-CSF and local proliferation of macrophages in experimental and human diseases.26 27 For instance, in MRL lpr/lpr mice, the onset of renal injury has been associated with increased renal expression of m-CSF, followed by the accumulation of macrophages in the kidney.11 28 In a recent study in MRL-lpr mice, m-CSF was stably transfected into tubular epithelial cells, which were then implanted under the renal capsule. This resulted in accumulation and/or proliferation of macrophages in the kidney.29
The major finding of the present study is that the expression of m-CSF was increased in the conjunctival tissue obtained from patients in whom OCP was in its earlier stages, and this increased expression of m-CSF correlated with the increased conjunctival accumulation of macrophages. We have shown not only an increased expression of m-CSF in conjunctiva of patients with OCP, but also have shown a positive correlation in the expression of m-CSF and accumulation of macrophages. Because m-CSF is the single major factor that helps in the growth and proliferation of monocytes/macrophages, an elevated level of m-CSF in conjunctiva of patients with OCP probably plays a significant role in the local proliferation of macrophages in the earlier stages of the disease process. Moreover, m-CSF not only plays a role in local macrophage proliferation but also is a chemotactic factor for monocytes.30 Thus, in addition to its role in local macrophage proliferation in conjunctiva affected by OCP, m-CSF may also promote recruitment of macrophages into the conjunctiva through a chemotactic mechanism. In our in vitro culture system, fibroblasts isolated from conjunctiva of patients with OCP produced significantly increased (approximately 1.7-fold) amounts of m-CSF. Thus, fibroblasts may also play an important role in the recruitment and local proliferation of macrophages in the conjunctiva of patients with OCP.
Although the pathogenesis of OCP is undoubtedly complex and incompletely understood, T-cellmediated immunity is thought to play a major role in the pathogenesis.31
32
33
It has been shown that in active OCP, there is a significantly increased infiltration of CD4+ T-helper cells and CD1+ Langerhans cells. Moreover, the ratio of T-helper/suppressor cells is higher in the conjunctiva of patients with OCP than in control subjects.33
34
35
To investigate the role of T-cellsecreted products (IL-1 and TNF-
) on the induction of m-CSF by conjunctival fibroblasts, we performed in vitro studies using IL-1
and TNF-
. When fibroblasts cultured from normal control conjunctiva were treated with various concentrations of IL-1
or TNF-
, compared with untreated cells, an increased level of m-CSF was detected in both IL-1
and TNF-
treated fibroblasts and in their supernatants. These results indicate that IL-1
and TNF-
induce expression of m-CSF in conjunctival fibroblasts. When conjunctival fibroblasts were treated with IL-1
and TNF-
for 6 hours, a significant induction of m-CSF mRNA by IL-1
and TNF-
was noted. Similar observations have been made by other investigators.36
37
Our results are in accord with earlier studies in which placental fibroblast-derived GM-CSF and m-CSF were shown to be regulated by trophoblast-derived cytokines IL-1 and TNF-
.36
Similarly, IL-1 and TNF-
induced the production of m-CSF by human articular cartilage and chondrocytes, whereas actinomycin D and cycloheximide inhibited both the basal and IL-1
induced production of m-CSF, suggesting a requirement for de novo RNA and protein synthesis.37
In our study, induction of m-CSF was noted in TNF-
and IL-1
treated cells. The mechanism by which TNF-
or IL-1 regulates the induction of m-CSF was not studied. However, earlier studies have shown that TNF-
and IL-1 exert their functions through activation of nuclear transcription factor NF-
B.38
Although the role of NF-
B in TNF-
and IL-1induced m-CSF expression by conjunctival fibroblasts is not yet known, NF-
B has been shown to be a transcriptional regulator of m-CSF in various other cell lines.39
40
Further studies are underway to determine the role of NF-
B in the IL-1
and TNF-
induced increased expression and production of m-CSF by conjunctival fibroblasts in patients with OCP.
Several studies have examined the expression of m-CSF in various human and experimental diseases, and an increased expression of m-CSF and local proliferation of macrophages was seen during the disease process. For example, local proliferation of alveolar macrophages under the influence of m-CSF and GM-CSF is involved during chronic inflammation and pulmonary fibrosis.16 More important, a similar association between increased expression of m-CSF and increased accumulation of macrophages was seen in various human renal diseases, and these locally proliferating macrophages appeared to intensify the inflammatory responses and subsequent tissue injuries in the kidney.12 Because m-CSF plays a crucial role(s) in growth and proliferation of monocytes/macrophages,28 30 41 it is thought that increased levels of m-CSF in conjunctival sections may have a key regulatory role for macrophage recruitment as well as local proliferation in conjunctiva of patients with OCP.
A local change of microenvironment may explain why the lesions in OCP are not generalized but rather are confined to the conjunctiva. Conjunctival fibroblast-secreted products, including m-CSF, may change the local microenvironment, and thus could eventually facilitate and/or intensify the local immunoinflammatory responses and subsequent conjunctival fibrosis. Understanding the precise cellular and molecular events that alter the local microenvironment in OCP conjunctiva may facilitate the development of organ-specific therapeutic strategies to treat and/or prevent the progression of irreversible conjunctival scarring in OCP.
In conclusion, the expression and production of m-CSF is increased in the conjunctiva of patients with OCP. Increased expression of m-CSF may be associated with recruitment and accumulation of macrophages and thereby could enhance inflammatory responses. It is possible that macrophage-derived fibrogenic factors contribute to the irreversible scarring that occurs in conjunctiva of patients with OCP.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication January 9, 2002; revised May 1, 2002; accepted May 29, 2002.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: A. Razzaque Ahmed, Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, MA 02115; razzaque_ahmed{at}hms.harvard.edu.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P T Yang, W G Xiao, L J Zhao, J Lu, L M He, H KASAI, and M Ito Increase in the level of macrophage colony-stimulating factor in patients with systemic lupus erythematosus Ann Rheum Dis, March 1, 2008; 67(3): 429 - 430. [Full Text] [PDF] |
||||
![]() |
S. Yamagami, S. Yokoo, S. Amano, and N. Ebihara Characterization of Bone Marrow Derived Cells in the Substantia Propria of the Human Conjunctiva Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4476 - 4481. [Abstract] [Full Text] [PDF] |
||||
![]() |
P-T Yang, H Kasai, W-G Xiao, L-J Zhao, L-M He, A Yamashita, X-W Deng, and M Ito Increased expression of macrophage colony-stimulating factor in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis, December 1, 2006; 65(12): 1671 - 1672. [Full Text] [PDF] |
||||
![]() |
M. J. Canizares, D. I. Smith, M. S. Conners, K. J. Maverick, and M. P. Heffernan Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients. Arch Dermatol, November 1, 2006; 142(11): 1457 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Heffernan and D. D. Bentley Successful treatment of mucous membrane pemphigoid with infliximab. Arch Dermatol, October 1, 2006; 142(10): 1268 - 1270. [Full Text] [PDF] |
||||
![]() |
M. S. Razzaque, C. S. Foster, and A. R. Ahmed Role of Macrophage Migration Inhibitory Factor in Conjunctival Pathology in Ocular Cicatricial Pemphigoid Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1174 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Razzaque, B. S. Ahmed, C. S. Foster, and A. R. Ahmed Effects of IL-4 on Conjunctival Fibroblasts: Possible Role in Ocular Cicatricial Pemphigoid Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3417 - 3423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Razzaque, C. S. Foster, and A. R. Ahmed Role of Connective Tissue Growth Factor in the Pathogenesis of Conjunctival Scarring in Ocular Cicatricial Pemphigoid Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1998 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Razzaque, C. S. Foster, and A. R. Ahmed Role of Collagen-Binding Heat Shock Protein 47 and Transforming Growth Factor-{beta}1 in Conjunctival Scarring in Ocular Cicatricial Pemphigoid Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1616 - 1621. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |